StockNYSEABBV
AbbVie
$265.12
-0.00 (-0.00%)today
Valuation & earnings
- P/E ratio
- 74.68
- Forward P/E
- 16.3
- EPS (ttm)
- $3.55
- Forward EPS
- $16.27
- Price/book
- -78.93
- PEG ratio
- 0.54
- Dividend yield
- 2.61%
- Payout ratio
- 190.4%
Financials (ttm)
- Revenue (ttm)
- 64.4B
- Revenue growth
- 10.2%
- Profit margin
- 9.8%
- Total cash
- 6.6B
- Total debt
- 70.9B
Earnings (EPS)
| Quarter | Estimate | Actual | Surprise |
|---|---|---|---|
| Sep 30, 2025 | 1.78 | 1.86 | +4.23% |
| Dec 31, 2025 | 2.65 | 2.71 | +2.16% |
| Mar 31, 2026 | 2.67 | 2.65 | -0.77% |
| Jun 30, 2026 | 3.61 | 3.65 | +1.15% |
Next earnings date: Oct 29, 2026
Analyst view
Consensus ratingBuy30 analysts
Strong buy 8Buy 16Hold 5Strong sell 1
12-month price targetsImplied upside: +5.09%
200
278.61
328
LowCurrent priceHigh
Dividends
- Dividend yield
- 2.61%
- Dividend (annual)
- $6.92
- Ex-dividend date
- Oct 15, 2026
Recent payments
Jul 15, 2026 · $1.73Apr 15, 2026 · $1.73Jan 16, 2026 · $1.73Oct 15, 2025 · $1.64Jul 15, 2025 · $1.64
Latest news
(English)The Peptide Boom That Isn’t About Your Muscles
The Wall Street JournalSep 25, 2026
RNAi drug specialist ADARx raises $446M IPO
BioPharma DiveSep 25, 2026
AbbVie vs. Novo Nordisk: Which Drug Giant Stock Is a Better Buy in 2026?
Motley FoolSep 24, 2026
AbbVie vs. Eli Lilly: Which Star Pharma Stock Is a Better Buy in 2026?
Motley FoolSep 24, 2026
AbbVie Stays Flat as 6,000-Property AI Hunts Better Molecules
GuruFocus.comSep 24, 2026
Can Eli Lilly Stock Catch Up To Rivals It Outgrows?
TrefisSep 24, 2026
Related products
How visible is AbbVie in AI search?
We ask AI search engines about AbbVie and its market — live — and measure whether and how prominently the brand appears in their answers.
No AI visibility check has been run for AbbVie yet.
Run a live check to see how AI search engines talk about this brand right now.
Is your brand this visible in AI search?
Aurora tracks your brand across 7 AI search engines — visibility, share of voice and the sources that shape AI answers.